These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4834569)

  • 1. Proceedings: The effects of different doses of chenodeoxycholic acid and of withdrawing treatment on bile lipid composition and liver function in patients with gallstones.
    Mok HY; Bell GD; Dowling RH
    Gut; 1974 Apr; 15(4):340. PubMed ID: 4834569
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones.
    Mok HY; Bell GD; Dowling RH
    Lancet; 1974 Aug; 2(7875):253-7. PubMed ID: 4135688
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of gallstones with chenodeoxycholic acid and phenobarbital.
    Coyne MJ; Bonorris GG; Chung A; Goldstein LI; Lahana D; Schoenfield LJ
    N Engl J Med; 1975 Mar; 292(12):604-7. PubMed ID: 1089875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: Is intermittent chenodeoxycholic acid therapy feasible for dissolving gallstones? The speed of change in biliary lipids and bile acids after starting and stopping treatment.
    Iser JH; Murphy GM; Dowling RH
    Gut; 1975 Oct; 16(10):840. PubMed ID: 1205324
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver structure and function in cholelithiasis: effect of chenodeoxycholic acid.
    Bell GD; Mok HY; Thwe M; Murphy GM; Henry K; Dowling RH
    Gut; 1974 Mar; 15(3):165-72. PubMed ID: 4152191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pathophysiology basis of gallstones dissolution (author's transl)].
    Erb W
    Leber Magen Darm; 1974 Apr; 4(2):72-4. PubMed ID: 4828907
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic toxicity in the rhesus monkey treated with chenodeoxycholic acid for 6 months: biochemical and ultrastructural studies.
    Dyrszka H; Salen G; Zaki FG; Chen T; Mosbach EH
    Gastroenterology; 1976 Jan; 70(1):93-104. PubMed ID: 812760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid.
    Barbara L; Roda E; Roda A; Sama C; Festi D; Mazzella G; Aldini R
    Digestion; 1976; 14(3):209-19. PubMed ID: 955328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K; Epple-Gutsfeld M; Leiss O
    Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary lipid composition in normalipidemic and prebeta hyperlipoproteinemic gallstone patients. Influence of sucrose feeding of the patients on the biliary lipid composition.
    Cahlin E; Jönsson J; Nilsson S; Scherstén T
    Scand J Gastroenterol; 1973; 8(5):449-56. PubMed ID: 4356589
    [No Abstract]   [Full Text] [Related]  

  • 15. Bile lipid secretion in obese and non-obese individuals with and without gallstones.
    Reuben A; Maton PN; Murphy GM; Dowling RH
    Clin Sci (Lond); 1985 Jul; 69(1):71-9. PubMed ID: 4064557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones.
    Thistle JL; Hofmann AF
    N Engl J Med; 1973 Sep; 289(13):655-9. PubMed ID: 4580472
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis].
    Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J
    Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120
    [No Abstract]   [Full Text] [Related]  

  • 18. Chenodeoxycholic acid therapy of gallstones.
    Dowling RH
    Clin Gastroenterol; 1977 Jan; 6(1):141-63. PubMed ID: 330046
    [No Abstract]   [Full Text] [Related]  

  • 19. Gallstone dissolution in man using chenodeoxycholic acid.
    Bell GD; Whitney B; Dowling RH
    Lancet; 1972 Dec; 2(7789):1213-6. PubMed ID: 4117706
    [No Abstract]   [Full Text] [Related]  

  • 20. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
    Sahlin S
    Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.